Indication
Haemophilus influenzae bronchitis
*Haemophilus influenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucous membranes. Read more about Haemophilus influenzae bronchitis
202 drugs 81 manufacturers
Drugs that treat it
Common Haemophilus influenzae bronchitis therapies.
AMOXICILLIN-CLAVULANATE POTASS (amoxicillin/potassium clavulanate)
CEFUROXIME (cefuroxime axetil)
CEFPROZIL
CEFDINIR
CEFDINIR
CEFPODOXIME PROXETIL
AZTREONAM
LEVAQUIN (levofloxacin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Haemophilus influenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucous membranes.
It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H.
influenzae* strains, often presenting as an acute infection or an acute bacterial exacerbation of chronic bronchitis in individuals with underlying pulmonary disease such as chronic obstructive pulmonary disease (COPD) or bronchiectasis.
Pathophysiologically, the organism adheres to damaged respiratory epithelium and evades mucociliary clearance, resulting in mucosal inflammation, hypersecretion, persistent cough, purulent sputum production, and dyspnea.
- nih.gov
*Haemophilus influenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucous membranes It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H. influenzae* strains It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H. influenzae* strains, often presenting as an acute infection or an acute bacterial exacerbatio...
- cdc.gov
It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H. influenzae* strains
- nih.gov
It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H. influenzae* strains, often presenting as an acute infection or an acute bacterial exacerbation of chronic bronchitis in individuals with underlying pulmonary disease such as chronic obstructive pulmonary disease (COPD) or bronchiectasis
- cdc.gov
Pathophysiologically, the organism adheres to damaged respiratory epithelium and evades mucociliary clearance, resulting in mucosal inflammation, hypersecretion, persistent cough, purulent sputum production, and dyspnea
Personalize your experience
Follow Haemophilus influenzae bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.